Pre-emptive Levetiracetam versus Pregabalin for postoperative analgesia after laparoscopic cholecystectomy. A prospective controlled trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202406773298479

Enrollment

120

Registered

2024-06-13

Start date

2023-08-31

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

placebo tablet

pregapaline tablet

levetiracetam

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • (ASA) grade I and II. • Both gender; male and female. • Elective laparoscopic cholecystectomy surgery. • Age: from 18 to 60 years old

Exclusion criteria

Exclusion criteria: • (ASA) grade III and IV. • Complicated surgery (open syrgery cholecystectomy). • Cardiac disease(coronary, valvular, hypertensive). • Morbid obese patients(BMI more than 40) • Diabetic or hypertensive patients.

Design outcomes

Primary

Measure	Time frame
postoperative pain	—

Secondary

Measure	Time frame
sedation score and hemodynamics	—

Countries

Egypt

Contacts

Public Contacthatem saber

prof.of anesthesia

hatem_saber@mans.edu.eg00201064970209

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026